Upload Avatar (500 x 500)
Guoliang Qing
Immunology and Metabolion
Wuhan University
Hubei
Language: English, Chinese
Metabolism
Genetics
Cancer
Therapy
Targeting
Molecular
Cellular
Treatment
Research
Clinical
Areas of Focus
- Metabolic abnormalities
- Immune escape
- Targeted cancer therapy
Work Experience
- 1999-2000 Shanghai Huaxin Biotechnology Co., Ltd., Project Director
- 2011-2015 Tongji Medical College, Huazhong University of Science and Technology, Professor
- 2016-Present Wuhan University Medical Research Institute, Professor
Academic Background & Achievements
- 1992-1996 Bachelor: Nanjing University, Department of Biological Sciences and Technology
- 1996-1999 Master: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
- 2000-2006 PhD: Rutgers, The State University of New Jersey at New Brunswick, Molecular Genetics
Publications
- Therapeutic targeting nudix hydrolase 1 creates a MYC-driven metabolic vulnerability, Ye M, Fang Y, Chen L, Song Z, Bao Q, Wang F, Huang H, Xu J, Wang Z, Xiao R, Han M, Gao S, Liu H, Jiang B, Qing G, 2024
- HILPS, a long noncoding RNA essential for global oxygen sensing in human, Chen Z, Chen C, Xiao L, Tu R, Yu M, Wang D, Kang W, Han M, Huang H, Liu H, Zhao B, Qing G, 2023
- The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma, Wang D, Yin Z, Wang H, Wang L, Li T, Xiao R, Xie T, Han R, Dong R, Liu H, Liang K, Qing G, 2023
- EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation, Wang L, Chen C, Song Z, Wang H, Ye M, Wang D, Kang W, Liu H, Qing G, 2022
- Polo-like Kinase-1 regulates MYC stabilization and activates a feed-forward circuit promoting tumor survival, D, Yue M, Su H, Ren P, Jiang J, Li F, Hu Y, Du H, Liu H, Qing G, 2016
Awards
- 2009 Ruth L Kirschstein National Research Award, National Cancer Institute, USA
- 2012 Hubei Province Hundred Talents Program Distinguished Expert
- 2013 New Century Excellent Talents in University, Ministry of Education, China
